Terumo Corp  

(Public, TYO:4543)   Watch this stock  
Find more results for 4543
3,820.00
-60.00 (-1.55%)
Feb 10 - Close
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 3,760.00 - 3,920.00
52 week 2,728.00 - 4,190.00
Open 3,920.00
Vol. 3.10M
Mkt cap 1.45T
P/E 31.75
Div/yield 19.00/0.92
EPS 120.32
Shares 375.74M
Beta     -
Inst. own     -
May 6, 2016
Full Year 2016 Terumo Corp Earnings Release (Estimated) - 3:00PM GMT+9 - Add to calendar
Feb 4, 2016
Q3 2016 Terumo Corp Earnings Call (Japanese)
Feb 4, 2016
Q3 2016 Terumo Corp Earnings Release
Feb 4, 2016
Full Year 2016 Terumo Corp Revision of Earnings Forecast
Feb 4, 2016
Q3 2016 Terumo Corp Earnings Call
Nov 30, 2015
Terumo Corp at Nomura Investment Forum
  

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 12.02% 7.86%
Operating margin 18.12% 12.23%
EBITD margin - 22.09%
Return on average assets 6.75% 4.22%
Return on average equity 11.31% 7.19%
Employees 19,934 -
CDP Score - 11

Address

2-44-1, Hatagaya
SHIBUYA-KU, TKY 151-0072
Japan
+81-3-33748111 (Phone)
+81-3-33748399 (Fax)

Website links

External links

Description

TERUMO CORPORATION is manufacturer of medical supplies. The Hospital Products segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The Cardiac and Vascular Area segment is involved in the manufacture, purchase and sale of catheter systems, artificial heart and lungs, as well as artificial blood vessels, the manufacture and sale of therapeutic coils for cerebral aneurysm, sampling equipment and kits for platelet-rich plasma and concentrated bone-marrow cell, and large-bore sheaths. The Blood System segment is engaged in the manufacture, purchase and sale of blood transfusion-related products. It also manufactures and sells healthcare related products. As of March 31, 2013, the Company had 79 subsidiaries and 2 associated companies.

Officers and directors

Koji Nakao Director
Age: 68
Yutaro Shintaku President, Representative Director
Age: 59
Ryo Nishihata Senior Executive Officer, Director of Finance
Hiroshi Matsumura Executive Vice President, President of Hospital Company, Representative Director
Age: 62
Takayoshi Mimura Senior Managing Executive Officer, Chairman & General Manager of Subsidiary, Director
Age: 61
Akira Oguma Senior Managing Executive Officer, Director
Age: 62
Shoji Hatano Managing Executive Officer, Manager of Business Planning Office, Leader of Business Planning Group in Business Planning Office
Narushige Toda Senior Executive Officer, Director of Domestic Sales in Hospital Company
Hideo Arase Senior Executive Officer, President & Chief Executive Officer of Subsidiary, Director
Age: 60
David Perez Senior Executive Officer, President of Blood System Company, President & Chief Executive Officer of Subsidiary, Director
Age: 56